Choksi Laboratories

Choksi Laboratories received the Establishment Inspection Report from the United States Food and Drug Administration for its central laboratory at Indore, indicating closure of the inspection. The inspection was conducted between 17 August and 20 August 2026. Choksi Laboratories operated five laboratories at Indore, Vapi, Vadodara, Goa and Panchkula undertaking contract analytical testing and calibration for pharmaceutical, food, agriculture, chemical and construction customers. Revenue was Rs 4,622 lakh in the year to March 2026, with net profit of Rs 196 lakh. Receivables were around Rs 1,200 lakh, about 26% of revenue, with the over-365-day bucket rising.

Powered by Tijori

Choksi Laboratories' shareholders voted down the proposal to issue up to 3,50,000 convertible warrants on a preferential basis at an extraordinary general meeting on 17 October 2026. The company would not proceed with the issue and sought closure of its application for in-principle approval from BSE. Promoters and the proposed allottees abstained from voting on the resolution. The proposal had envisaged raising up to Rs 6.195 crore from Sunil Choksi, Himika Choksi and Stela Choksi at Rs 177 per warrant. Revenue was Rs 46.22 crore in the year to March 2026 with a net margin of 4.2%. The company operates five testing and calibration laboratories at Indore, Vapi, Vadodara, Goa and Panchkula.

Powered by Tijori

Choksi Laboratories' board approved the issuance of up to 350,000 convertible warrants to three members of its promoter group at Rs177 apiece, aggregating up to Rs6.19 crore. Each warrant carried a right to subscribe to one fully paid equity share of Rs10, with 25% payable on allotment and the balance on exercise within 18 months, subject to approval at an extraordinary general meeting on 17 October 2026. The proposed allottees were Sunil Choksi for 200,000 warrants, Himika Choksi for 100,000 warrants and Stela Choksi for 50,000 warrants. The testing company operated five laboratories from its Indore base and reported revenue of Rs46.22 crore with net profit of Rs1.96 crore in the year to March. Gearing stood at about 1.2 times after sustained debt repayment, while receivables of about Rs12 crore remained a heavy working-capital block. Revenue for the June quarter was Rs12.08 crore with net profit of Rs58 lakh.

Powered by Tijori

Sept 14 (Reuters) - Choksi Laboratories Ltd CHOA.BO:

• BOARD TO CONSIDER FUNDRAISING VIA SHARES OR CONVERTIBLE SECURITIES

Source text: ID:nBSE3D07C

Further company coverage: CHOA.BO

(([email protected];;))

Aug 21 (Reuters) - Choksi Laboratories Ltd CHOA.BO:

• CHOKSI LABORATORIES - USFDA INSPECTS CHOKSI LABORATORIES' CENTRAL LABORATORY IN INDORE FROM AUG 17-20, 2026

• CHOKSI LABORATORIES - RECEIVES 4 OBSERVATIONS FROM USFDA INSPECTION

Source text: ID:nBSE7ClVxQ

Further company coverage: CHOA.BO

(([email protected];))